Skip to main content
. 2018 Jan 30;90(5):e404–e411. doi: 10.1212/WNL.0000000000004888

Table 2.

Alterations in caffeine and metabolite levels in patients with Parkinson disease (PD) and controls

graphic file with name NEUROLOGY2017821272TT2.jpg